Asia Pacific Point of Care Diagnostic Market Report

Asia Pacific Point of Care Diagnostic Market Report, By Test Type (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing, Coagulation Monitoring, Pregnancy & Fertility Testing, Faecal Occult Testing, Haematology Testing, Tumour/Cancer Marker Testing, Urinalysis Testing, Drugs Abuse Testing , Cholesterol Testing), Mode of Prescription (Prescription based, Over the Counter), End User (Hospital/ Critical Care Centres, Ambulatory Care Settings, Research Laboratory, Home Care) and Country- Asia Pacific Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : 10841 | Publish Date : Upcoming | Industry : Healthcare | Geography : APAC


Point of care is also known as with patient testing which allows physicians and medical staff to perfectly obtained real time, lab quality diagnostic results in several minute rather than taking hours to diagnose. Through the use of portable blood analysers, testing at the point of care downsize the diagnostic process and aids in ensuring patients to obtained the most effective and efficient care when and where it is needed. Point of care testing enables staff to make rapid triage and treatment decisions at the time of diagnosis of patient’s conditions or monitoring treatment response. 

Market Dynamics- Asia Pacific Point of Care Diagnostic Market 

The Asia Pacific point of care diagnostic market is witnessing tremendous growth during forecast period of 2021 to 2027. The point of care diagnostic easier the testing process due to which clinicians can focus on what matters most for providing effective, quality patient care. The dynamic factors such as technological advancements and new product launches is propelling growth of Asia Pacific point of care diagnostic market. The rising funding for development of point of care products is also boosting growth of Asia Pacific point of care diagnostic market. However, pricing pressure owing to reimbursement cuts and budget constraints is hindering the growth of Asia Pacific point of care diagnostic market. 

COVID-19 Impact on Asia Pacific Point of Care Diagnostic Market 

The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the point of care diagnostic market. In addition, complete analysis of changes on point of care diagnostic expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The outbreak of COVID-19 has boosted the growth of diagnostic kits for rapid detection of diseases. There is somewhat mismatch between the demand and supply as there is complete shutdown in many countries due to outbreak of COVID-19. The rapidly growing number of COVID-19 cases and the growing pressure on governments for improving patient management has boosted the demand for rapid antigen testing kits which can effectively use in point if care settings. 


Asia Pacific Point of Care Diagnostic Market- Segmental Overview 

The Asia Pacific point of care diagnostic market is categorised into test type, mode of prescription, end user and country. 

Asia Pacific Point of Care Diagnostic Market by Test Type 

Product type such as glucose monitoring, cardiometabolic monitoring, infectious diseases monitoring, coagulation monitoring, pregnancy and fertility testing, faecal occult testing, haematology testing, tumour/cancer marker testing, urinalysis testing, drug abuse testing and cholesterol testing are comprised in the Asia Pacific point of care diagnostic market. In which urinalysis testing is also contributing to the growth of Asia Pacific point of care diagnostic market. The growing trend of home testing of biological samples is propelling growth of Asia Pacific point of care diagnostic market. The growing cases of urine infections is also boosting growth of Asia Pacific point of care diagnostic market. 

Asia Pacific Point of Care Diagnostic Market by Mode of Prescription 

Mode of prescriptions such as prescription based and over the counter product are comprised in the Asia Pacific point of care diagnostic market. In which prescription-based products is also contributing to the growth of Asia Pacific point of care diagnostic market. The rising awareness regarding use of point of care diagnostic products is boosting growth of Asia Pacific point of care diagnostic market.  The rising prevalence of long term and chronic diseases is also propelling growth of Asia Pacific point of care diagnostic market.

Asia Pacific Point of Care Diagnostic Market by End User 

End user such as hospitals/critical care centres, ambulatory care settings, research laboratories and home care are comprised in the Asia Pacific point of care diagnostic market. In which research laboratories are also contributing to the growth of Asia Pacific point of care diagnostic market. The rising research and development activities in point of care diagnostics is propelling growth of Asia Pacific point of care diagnostic market. The growing trend of home testing is also boosting growth of Asia Pacific point of care diagnostic market. 

Asia Pacific Point of Care Diagnostic Market by Country

The Asia Pacific point of care diagnostic market is studied for key countries such as India, China, Japan, Australia and South Korea. In which China followed by India and Japan are anticipated to dominate the market in 2020. The rising prevalence of infectious diseases is propelling growth of Asia Pacific point of care diagnostic market. The growing healthcare expenditure is also boosting growth of Asia Pacific point of care diagnostic market.  

Key Players in Point of Care Diagnostic Market

The major key players operating in the market of point of care diagnostic market are Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson And Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, Ekf Diagnostics, Trinity Biotech and Fluxergy among others. 

Key Developments in Point of Care Diagnostic Market

June 2019: Abott anouced the launch of Afinion HbA1c Dx Assay , a point of care test for diabetes.

June 2019: Quidel Corporation received US FDA approval to commercialize Quidel Triage TOX Drug Screen.

March 2019: Roche Diagnostics FDA approval for the VENTANA PD-L1 (SP142) Assay for identifying triple-negative breast cancer (TNBC) patients.

February 2019: Danaher acquired the Biopharma business of GE Life Sciences with an aim to established as a standalone operating company and strengthen the point of care diagnostics product portfolio.

The report analyses the point of care diagnostic market based on product type, mode of prescription, end user and country. Various types of products available in the point of care market are glucose monitoring, cardiometabolic monitoring, infectious diseases monitoring, coagulation monitoring, pregnancy and fertility testing, faecal occult testing, haematology testing, tumour/cancer marker testing, urinalysis testing, drug abuse testing and cholesterol testing. By mode of prescription, the market is segmented into the prescription based and over the counter products. Based on end users, the market is segmented into the hospital/critical care centres, ambulatory care settings, research laboratory and home care. The study also analyses the impact of COVID-19 on the point of care diagnostic market and it founds that the outbreak of COVID-19 has boosted the growth of diagnostic kits for rapid detection of diseases. There is somewhat mismatch between the demand and supply as there is complete shutdown in many countries due to outbreak of COVID-19. The rapidly growing number of COVID-19 cases and the growing pressure on governments for improving patient management has boosted the demand for rapid antigen testing kits which can effectively use in point if care settings. The study also analyses various major key players operating in the market. 

Why to buy this report

  • The report offers changing market dynamics in the point of care diagnostic markets industry, presenting historical, current and projected market size in terms of value (USD Million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of the point of care diagnostic market.
  • It presents a comprehensive assessment of countries exhibiting promising growth, potential and niche segments and a neutral perspective of the point of care diagnostic market
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of point of care diagnostic market